Russell Frank Company’s United Therapeutics UTHR Stock Holding History

Russell Frank Company’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$49.5M	Buy	444,172 +81,657	+23%	+$10.3M	0.09%	255
2015 Q4	$57.5M	Buy	362,515 +51,196	+16%	+$7.45M	0.1%	230
2015 Q3	$40.9M	Sell	311,319 -14,206	-4%	-$2.28M	0.08%	288
2015 Q2	$56.6M	Sell	325,525 -37,294	-10%	-$6.71M	0.09%	251
2015 Q1	$62.6M	Sell	362,819 -9,534	-3%	-$1.45M	0.11%	216
2014 Q4	$48.7M	Sell	372,353 -4,575	-1%	-$590K	0.09%	258
2014 Q3	$48.5M	Sell	376,928 -129,461	-26%	-$13.3M	0.09%	265
2014 Q2	$45.9M	Sell	506,389 -19,327	-4%	-$1.86M	0.08%	272
2014 Q1	$49.4M	Buy	525,716 +42,612	+9%	+$4.36M	0.09%	266
2013 Q4	$54.3M	Sell	483,104 -7,467	-2%	-$673K	0.1%	235
2013 Q3	$38.7M	Sell	490,571 -3,711	-0.8%	-$271K	0.07%	336
2013 Q2	$32.5M	Buy	+494,282	New	+$31.8M	0.06%	372

Other funds holding UTHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Russell Frank Company's UTHR Position: Q1 2016 in Review

Russell Frank Company increased its United Therapeutics (UTHR) stake by 23% in Q1 2016, buying an estimated $10.3M and bringing the position to 444,172 shares worth $49.5M. The position accounts for 0.09% of the portfolio, ranked #255.

Russell Frank Company first reported a position in UTHR in Q2 2013 and has held it in 12 quarters since. The position peaked at $62.6M in Q1 2015. 398 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

Russell Frank Company held 444,172 shares of United Therapeutics worth $49.5M as of Q1 2016.
Russell Frank Company bought 81,657 United Therapeutics shares in Q1 2016, an estimated $10.3M.
United Therapeutics made up 0.09% of Russell Frank Company's portfolio in Q1 2016, its #255 holding.
Russell Frank Company first reported a position in United Therapeutics in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's United Therapeutics position peaked at $62.6M in Q1 2015.
398 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.